Importantly, tirzepatide carries an FDA boxed warning for risk of thyroid C-cell tumors, and is contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
The regulatory pathway for biomarker approval adds additional complexity and delay to clinical implementation (Nisenblat et al., 2016)
Intriguingly, GLP-1 is secreted by intestinal cells not only in response to food but also to "inflammatory stimuli," and its levels correlate with disease severity in inflammation
Mistake 1: stopping creatine because of the scale The 2-4 pound water weight gain triggers panic
MC3R and MC5R activity has been investigated in the context of metabolic regulation and exocrine gland function respectively
The improvements in insulin sensitivity attributed to tirzepatide were only partly explained by weight loss, suggesting that the dual receptor agonism of tirzepatide provides distinct mechanisms for glycemic control beyond weight reduction